Related Experiment Video
Updated: Oct 22, 2025
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Fuscoside Attenuates Bone Loss in Bone Defects by Regulating The Rankl/Nlrp3/Opg Pathway in Rats
1Department of Traumatic Orthopedics, Chifeng Municipal Hospital, Chifeng, Inner Mongolia, China.
Objective:
This study evaluated the beneficial effect of fuscoside in the repair of bone defects (BDs) and the possible molecular mechanism thereof.
Materials And Methods:
In this experimental study, a BD was induced by drilling the rat tibia. The rats were then administered oral fuscoside, at 200 or 300 mg/kg, for 2 weeks. The effect of treatment was assessed based on the bone formation score and on the levels of cytokines and biochemical markers in serum. Tibial expression of the proteins involved in the Rankl/Nlrp3/Opg pathway was determined by quantitative reverse-transcription polymerase chain reaction and western blot assay, and histopathological changes by haematoxylin and eosin and TRAP staining.
Results:
In the fuscoside-treated BD rats, the bone formation score improved and inflammatory cytokine levels were reduced. The levels of biochemical markers improved as well, as did the expression of apoptosis proteins. Fuscoside also attenuated the expression of Rankl, Opg, Nlrp3, Runx2, Osterix, and Osteocalcin (Oc) proteins in the tibial tissue of the BD rats and reversed the abnormal histopathological changes.
Conclusion:
These results suggest that fuscoside improves BD repair by reducing the differentiation of osteoclasts and by regulating the Rankl/Nlrp3/Opg pathway.
Insights
Fuscoside enhances bone defect repair by reducing osteoclast differentiation and regulating the Rankl/Nlrp3/Opg pathway. This natural compound shows promise for improving bone regeneration and healing.
Area of Science:
- Biomaterials Science
- Orthopedic Research
- Pharmacology
Background:
- Bone defects (BDs) present a significant clinical challenge requiring effective therapeutic strategies.
- Understanding the molecular mechanisms underlying bone regeneration is crucial for developing novel treatments.
Purpose of the Study:
- To evaluate the efficacy of fuscoside in promoting bone defect repair.
- To elucidate the molecular mechanisms involved in fuscoside-mediated bone regeneration.
Main Methods:
- Bone defects were surgically induced in rat tibias.
- Rats received oral fuscoside (200 or 300 mg/kg) for two weeks.
- Bone formation, serum markers, protein expression (Rankl/Nlrp3/Opg pathway), and histopathology were analyzed.
Main Results:
- Fuscoside treatment significantly improved bone formation scores and reduced inflammatory cytokine levels.
- Biochemical markers and apoptosis protein levels showed improvement in fuscoside-treated rats.
- Fuscoside modulated the expression of key proteins in the Rankl/Nlrp3/Opg pathway and reversed abnormal histopathological changes.
Conclusions:
- Fuscoside effectively promotes bone defect repair in a rat model.
- The therapeutic effect of fuscoside involves the regulation of osteoclast differentiation and the Rankl/Nlrp3/Opg signaling pathway.
More Related Videos
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
05:55Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
